Skip to content

support@abbonews.com

Menu

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

NASDAQ: CVAC

Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents

Jennifer Tacker / 8 October 2024

LONDON – On Tuesday, Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) won their attempt to invalidate two […]

Pfizer and BioNTech Win Bid to Invalidate CureVac’s UK COVID Vaccine Patents Read More »

GSK

GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac

Zabih Ullah / 3 July 2024

On Wednesday, British drugmaker GSK (NYSE: GSK) bought partner CureVac (NASDAQ: CVAC) out of their alliance on influenza and COVID-19

GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac Read More »

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer

Copyright © 2024 abbonews.com.